Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
JAMA Ophthalmology
|
April 8, 2021
Survival Analysis vs Longitudinal Modeling With Multiple Imputation-a False Dichotomy-Reply
Catey Bunce, Dun Jack Fu, Irene Stratton
Eye (London, England)
|
January 21, 2026
Infographic: Efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative age-related macular degeneration using the Lumithera Valeda Light Delivery System: 13-month results from the LIGHTSITE III trial
Anushka Irodi, Livia Faes, Dun Jack Fu
Eye (London, England)
|
February 19, 2025
Letter in reply to: Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation
Dun Jack Fu, Sobha Sivaprasad, Livia Faes
Ophthalmology and Therapy
|
December 1, 2017
A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis
Srilakshmi M Sharma, Dun Jack Fu, Kanmin Xue
Eye (London, England)
|
January 12, 2026
Infographic: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW and RAINBOW Extension Study)
Venughanan Manikavasagar, Livia Faes, Alasdair Kennedy, et al.
Eye (London, England)
|
February 23, 2026
Infographic: ranibizumab for neovascular age-related macular degeneration: the MARINA study
Francesca Lamanna, Eleonora Riotto, Livia Faes, et al.
Eye (London, England)
|
February 19, 2026
Infographic: effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the centre of the macula and good visual acuity (DRCR Protocol V Study)
Eleonora Riotto, Venughanan Manikavasagar, Francesca Lamanna, et al.
Eye (London, England)
|
February 16, 2026
Infographic: five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (DRCR Protocol T Extension Study)
Eleonora Riotto, Francesca Lamanna, Venughanan Manikavasagar, et al.
Eye (London, England)
|
March 24, 2026
Infographic: AREDS<sup>1</sup>&AREDS<sup>2</sup>-oral supplementation with antioxidants for age-related macular degeneration (AMD)
Darshigaa Gurumoorthy, Eleonora Riotto, Livia Faes, et al.
The British Journal of Ophthalmology
|
April 25, 2024
Survival of medical treatment success in primary open-angle glaucoma and ocular hypertension
Dun Jack Fu, Ebenezer Ademisoye, Vanessa Shih, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
JAMA Ophthalmology
|
April 8, 2021
Survival Analysis vs Longitudinal Modeling With Multiple Imputation-a False Dichotomy-Reply
Catey Bunce, Dun Jack Fu, Irene Stratton
Eye (London, England)
|
January 21, 2026
Infographic: Efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative age-related macular degeneration using the Lumithera Valeda Light Delivery System: 13-month results from the LIGHTSITE III trial
Anushka Irodi, Livia Faes, Dun Jack Fu
Eye (London, England)
|
February 19, 2025
Letter in reply to: Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation
Dun Jack Fu, Sobha Sivaprasad, Livia Faes
Ophthalmology and Therapy
|
December 1, 2017
A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis
Srilakshmi M Sharma, Dun Jack Fu, Kanmin Xue
Eye (London, England)
|
January 12, 2026
Infographic: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW and RAINBOW Extension Study)
Venughanan Manikavasagar, Livia Faes, Alasdair Kennedy, et al.
Eye (London, England)
|
February 23, 2026
Infographic: ranibizumab for neovascular age-related macular degeneration: the MARINA study
Francesca Lamanna, Eleonora Riotto, Livia Faes, et al.
Eye (London, England)
|
February 19, 2026
Infographic: effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the centre of the macula and good visual acuity (DRCR Protocol V Study)
Eleonora Riotto, Venughanan Manikavasagar, Francesca Lamanna, et al.
Eye (London, England)
|
February 16, 2026
Infographic: five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (DRCR Protocol T Extension Study)
Eleonora Riotto, Francesca Lamanna, Venughanan Manikavasagar, et al.
Eye (London, England)
|
March 24, 2026
Infographic: AREDS<sup>1</sup>&AREDS<sup>2</sup>-oral supplementation with antioxidants for age-related macular degeneration (AMD)
Darshigaa Gurumoorthy, Eleonora Riotto, Livia Faes, et al.
The British Journal of Ophthalmology
|
April 25, 2024
Survival of medical treatment success in primary open-angle glaucoma and ocular hypertension
Dun Jack Fu, Ebenezer Ademisoye, Vanessa Shih, et al.
Page
of 6